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Abstract
Informative priors can be a useful tool for epidemiologists to handle problems of sparse data in 
regression modeling. It is sometimes the case that an investigator is studying a population exposed 
to two agents, X and Y, where Y is the agent of primary interest. Previous research may suggest 
that the exposures have different effects on the health outcome of interest, one being more harmful 
than the other. Such information may be derived from epidemiologic analyses; however, in the 
case where such evidence is unavailable, knowledge can be drawn from toxicologic studies or 
other experimental research. Unfortunately, using toxicologic findings to develop informative 
priors in epidemiologic analyses requires strong assumptions, with no established method for its 
utilization. We present a method to help bridge the gap between animal and cellular studies and 
epidemiologic research by specification of an order-constrained prior. We illustrate this approach 
using an example from radiation epidemiology.
Associations estimated from sparse data tend to be highly imprecise and can be biased.1 
Informative priors—external knowledge used to inform and stabilize measures of 
association—may help address these problems. Although the benefits of informative priors 
have been well documented in other fields, they are rarely utilized in occupational and 
environmental epidemiology.2,3
We introduce a simple approach using order-constrained priors to incorporate prior 
knowledge regarding exposure-disease associations from toxicologic research into 
epidemiologic analyses. This approach informs parameter estimation based on the direction 
of effect of one parameter relative to another within the same regression model. We 
illustrate this approach by estimating associations between two exposures (beta radiation 
from tritium intakes and external exposure to gamma radiation) and leukemia mortality 
among workers employed at a nuclear facility.
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Bayesian Priors Using Toxicologic Models
A Bayesian analysis offers a coherent method to incorporate information from prior research 
when estimating an association in an epidemiologic study. A Bayesian analysis may often be 
an improvement over one confined to information within a single study.4,5 Informative 
priors for the parameters describing an exposure-disease association are often obtained from 
prior epidemiologic studies in comparable populations. When there is no previous 
epidemiologic research on human health effects of exposure to an agent, experimental or 
toxicologic evidence on whole organisms, tissues, cells, or molecules may be informative.
Experimental studies that use nonhuman animals or cell lines draw strength from their 
ability to control the exposures of interest, experimental conditions, and assessment of 
outcomes. However, use of evidence obtained from experimental studies to inform 
estimation of an association in an epidemiologic study may be complicated by differences in 
physiologic and pathologic responses across species6 and differences in the endpoints under 
study. For example, in radiation research, molecular and cellular studies often evaluate 
endpoints such as chromosomal aberrations, DNA strand breaks, or cell death, whereas 
epidemiologic studies often focus on cancer incidence or mortality.7–9 Nonetheless, 
experimental research may provide useful information for specifying an informative prior 
for the parameters describing an exposure-disease association.
Order-Constrained Priors
An order-constrained prior can provide an intuitive way of integrating toxicology results 
while avoiding the pitfalls of trying to directly apply effect estimates across species or 
outcomes. By utilizing an order constraint, the researcher imposes a structure to the 
relationship between the exposure and outcome of interest. For example, if we want to 
impose a monotonic order constraint for categories of exposure, β1, β2 and β3, we could 
specify an order-constrained model such that β1 ≤ β2 ≤ β3. In a Bayesian setting, which often 
relies on drawing large numbers of samples from the posterior distribution, we can impose 
that constraint by ensuring that each sample adheres to the specified ordering.10,11
Order-constrained parameters have a history of use in the dose-response literature10–12; 
however, their utility need not be limited to scenarios where the researcher is interested in 
specifying the direction and magnitude of a dose-response relationship for categories of a 
single exposure. Suppose that the investigator is studying a population exposed to agents X 
and Y, and is interested in disease, D, where Y is the agent of primary interest and X is 
another agent quantified using the same unit of measurement. For each agent we have 
experimental evidence regarding its association with outcome, Z, which might represent a 
suspected biologic marker (eg, a cellular transformation or change in disease biomarker) or 
induction of a tumor in an animal model. In a logistic regression setting, the associations 
between agents X and Y and disease endpoint Z might be described by two models of the 
form logit(Pr[Z = 1]) = α0+α1X and logit(Pr[Z = 1]) = α′0+α′1Y.
Suppose that the results from experimental research suggest that Y is more strongly 
associated with the outcome, Z, than X (eg, α′1 > α1). The investigator may incorporate such 
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evidence by specifying an ordered-constrained prior informed by the rank ordering of the 
exposure effects regarding outcome Z when fitting a model for the outcome, D, in relation to 
the coexposures, X, Y. Such a model may take the form logit(Pr[D = 1]) = β0 + β1X + β2Y, 
where the prior for β1 may be vague, while the prior for the parameter of primary interest, 
β2, reflects the ordered constrained prior assumption β2 ≥ β1.
A major distinction between order constraints and priors typical in Bayesian analysis is that 
the former assigns a probability of zero to those parameter values that do not adhere to the 
constraint. Therefore, a researcher who uses this approach should have a high degree of 
confidence in the evidence that informs such priors. When this is the case, specifying an 
order-constrained prior may yield substantial gains in estimation of the effect of the agent of 
primary interest.
Conditions for using an ordered-constrained prior are encountered in some important, 
interesting settings in occupational and environmental research. Considering investigations 
of the health effects of various congeners of polychlorinated biphenyl, where people are 
exposed to two or more congeners, exposure intensities vary (and are not perfectly 
correlated), and toxicologic data suggest prior expectations for differences in biologic 
effects between congener types. Studies of respiratory health effects associated with 
inhalation of asbestos fibers provide another setting in which these conditions may hold, 
because people are typically exposed to fibers of various dimensions, and toxicologic data 
suggest prior expectations or differences in biological effects as a function of fiber 
dimension. Although available human evidence may be insufficient to posit a prior for the 
association between the agent of primary concern and outcome of interest, toxicologic data 
may be informative regarding ordered constraints for two or more parameters.
Example
We present an example utilizing an order-constrained prior to estimate the association 
between tritium exposure and leukemia mortality in a cohort of workers who were also 
exposed to gamma radiation at the Savannah River Site nuclear facility. The Savannah River 
Site has been identified as one of the largest US occupational cohorts with potential tritium 
exposure. Nonetheless, examination of the association with cancer risk is hindered by the 
fact that tritium is received at low levels and occurs with exposure to other occupational 
hazards.13,14 Incorporation of prior knowledge via order-constrained priors was investigated 
as a method to stabilize risk estimates.
The Savannah River Site is a nuclear facility near Aiken, SC. Activities began in 1951, with 
the first production reactor going critical in December 1953. E. I. du Pont de Nemours and 
Company operated the site until March 31, 1989, when Westinghouse Savannah River 
Company took over.15,16 Between 1950 and 1986, 21,204 people were known to have been 
hired by DuPont to work at the site. We restricted our cohort to those who worked at least 90 
days, and had no history of employment at another Department of Energy facility.13 
Additionally, workers were excluded if they were missing information on sex, date of birth, 
name, Social Security Number, or date of first hire. This leaves a cohort of 18,883 workers 
for whom individual, annual dose records have either been computed or estimated in 
previous research. Workers were followed through 2002 to obtain vital status information. 
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In the current analysis, the outcomes, leukemia, and leukemia excluding chronic 
lymphocytic leukemia are based on International classification of disease in the United 
States codes (International classification of disease in the United States 9 codes 204–207; 
those with code 204.1 represent cases of chronic lymphocytic leukemia). Analyses 
excluding chronic lymphocytic leukemia are conducted because of potential differences in 
latency of chronic lymphocytic leukemia compared with acute and myeloid forms of 
leukemia.17
The primary type of external penetrating radiation exposure at the Savannah River Site was 
gamma rays. Neutrons were present in some areas, but constituted a small fraction of 
collective dose; therefore, we do not attempt to assess independent neutron effects.18 
Penetrating forms of ionizing radiation were measured with film badges until 1970 and 
thermoluminescent dosimeters thereafter.16 Radiation doses from tritium intakes were 
estimated from urinalysis. We consider tritium and gamma doses independently in units of 
Gray (Gy).19 Estimated annual whole-body dose values in Sieverts (Sv)—the sum of 
gamma, tritium, and neutron doses—are available for all employment years; 6% of these 
records were estimated using a “nearby” method, previously described in Richardson et al.16 
Annual whole-body dose estimates were utilized to derive annual tritium dose estimates for 
those person-years with missing information regarding the contribution of tritium to their 
cumulative annual whole-body dose. In total, there are 56.2 Gy of individual, annual tritium 
dose records, of which 4.3 Gy (7.7%) were estimated through use of a job-exposure 
matrix.20 Imputed values of tritium dose were validated by combining gamma and tritium 
doses to recalculate the excess relative rate (RR)/10mSv whole-body radiation obtained by 
Richardson et al.13 Point estimates were the same in the dataset with imputed tritium dose 
values, with a modest gain in precision.
Dose-response relationships are estimated using an excess relative rate model of the form:
where eαi indexes the baseline rate within stratum i, β represents the excess RR for a given 
exposure, g represents cumulative gamma radiation dose, and t represents cumulative tritium 
dose. Cumulative doses, expressed in mGy, are lagged 3 years from the date of death for 
leukemia cases and from the risk set time for controls. As in prior studies, we conducted 
nested case-control analyses by creating risk sets matched on age, sex, race, pay code, birth 
cohort, and employment status.13 All relevant confounders were matched in the study 
design, so no additional covariates are included in this analysis.
In a recent systematic review of animal and cellular studies, Little and Lambert21 conclude 
that a reasonable value for the biological effectiveness of an absorbed dose arising from 
tritium intake is two to three times that for an absorbed dose from external exposure to 
gamma radiation. In a more common Bayesian analysis, a researcher might incorporate the 
estimate of effect from previous work as a prior in the current analysis. Because these results 
are exclusive to leukemia events in animals and cancer precursors in animal and human 
cells, researchers may feel uncomfortable specifying a value for the effect (ie, the prior 
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mean) based on these studies. However, although the outcomes of interest varied across 
studies, the direction of effect of tritium relative to gamma radiation dose is consistent based 
upon evidence from in vivo and in vitro studies21–23; that is, the biologic effectiveness of 
tritium is always greater than that of gamma radiation. Therefore, we specify an order-
constrained prior that β2 ≥ β1 10 The order constraint allows us to specify that, although we 
are uncertain about the specific magnitude of the difference between β2 and β1, we are 
certain that tritium causes more biologic damage than gamma radiation. In a Markov chain 
Monte Carlo implementation of the analysis this translates to drawing samples of β2 that are 
never less than β1. The form of the distribution for the parameters is specified as normal but 
noninformative over admissible values, where β1 ~ N(μ = 0, σ2 = 100,000) and β2 ~ N(μ = 0, 
σ2 = 100,000), truncated below by β1.
All analyses were conducted using SAS procedure Markov chain Monte Carlo (V 9.2, SAS 
Institute, Cary, NC). Posterior distributions are presented as 90% highest posterior density 
intervals for consistency with radiation epidemiology literature. All models were run three 
times as a diagnostic check, to ensure that results are not sensitive to starting values of the β1 
and β2. In addition, to minimize simulation error, these models were run for 5 million 
iterations with a burn-in of 100,000 iterations, and all sampled values after the burn-in 
period were retained.
Table 1 documents the distribution of cases by categories of dose for tritium and gamma 
radiation. This illustrates the fact that tritium is received at lower levels than gamma 
radiation, for which the dose distribution is larger. The Pearson correlation of tritium and 
penetrating radiation is 0.64 for cases and 0.34 for cases and controls.
Table 2 presents Markov chain Monte Carlo analyses of leukemia and leukemia excluding 
chronic lymphocytic leukemia. When the model includes a noninformative prior for β1 and 
no order constraint on β2, the estimate of the excess RR/10mGy due to gamma radiation (β1) 
for leukemia and leukemia excluding chronic lymphocytic leukemia are 0.053 (90% highest 
posterior density = −0.025 to 0.142) and 0.176 (0.011 to 0.375), respectively. The estimated 
excess RR/10mGy due to tritium (β2) for leukemia and leukemia excluding chronic 
lymphocytic leukemia are 0.141 (−0.323 to 0.649) and −0.281 (−1.136 to 0.548), 
respectively. The Figure illustrates the relative weight of information based on kernel 
density estimates of posterior distributions for β1 and β2 when the order constraint is 
excluded.
When we integrate the order-constrained prior so that β2≥ β1, retaining a noninformative 
prior for β1, estimates of the excess RR/10mGy due to gamma radiation for leukemia and 
leukemia excluding chronic lymphocytic leukemia are 0.034 (−0.031 to 0.110) and 0.082 
(−0.017 to 0.206), respectively. The estimated excess RR/10mGy due to tritium for 
leukemia and leukemia excluding chronic lymphocytic leukemia are 0.298 (0.027 to 0.702) 
and 0.344 (0.049 to 0.817), respectively. The width of the confidence bounds indicates the 
change in precision that results from integration of the order-constrained prior. The posterior 
correlations between β1 and β2 when examining leukemia and leukemia excluding chronic 
lymphocytic leukemia are −0.0118 and 0.1635, respectively. Additionally, the Figure 
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illustrates the shift in the distribution of β2 relative to β1, the latter of which is clearly better 
identified in this data.
DISCUSSION
In certain settings, use of an ordered-constrained prior can help bridge the gap between 
toxicologic studies and epidemiologic research. The appealing aspect for epidemiologists 
attempting to apply evidence from animal and cellular models is that this approach 
incorporates prior information only on the relative magnitude of effect of various exposures
—exactly the type of information that is often available. We present a case where a highly 
imprecise parameter (tritium) is informed by a more well-identified parameter (gamma) 
based on a wealth of a priori experimental evidence; the relative weight of information 
regarding each parameter is summarized in the Figure.
It is important to consider the strength of information that supports the use of an order 
constraint. In epidemiologic analyses, counterfactuals are unobservable; however, 
experimental research can come quite close. Use of cell lines and genetically identical 
animals allows researchers to observe the outcomes that occur under controlled exposure 
scenarios, while characterizing the physical properties that may explain why they act as they 
do. We focus on the effect of radiation doses from intakes of tritium and from external 
exposure to gamma rays. Tritium is a radioisotope of hydrogen that emits beta radiation via 
the release of electron energy as it decays from H3 to He3.24 Unlike external penetrating 
radiation such as gamma- and x-rays, the low-energy beta radiation emitted by tritium 
travels only a short distance in tissue. However, beta radiation from tritium is known to have 
a higher average ionization density than gamma radiation; this leads to higher cellular level 
damage per unit dose.25–27 Both physical and experimental research provides strong 
evidence that the carcinogenic effectiveness per unit dose from intakes of tritium is as great 
as or greater than that for gamma radiation, a result that has been repeated over many 
years.9,26,28–30 Thus, changes in the estimates of parameters should be regarded as an 
improvement when informed by a constraint based on highly defensible and repeated 
research.
Current research treats the sum of gamma and tritium dose as a single exposure metric, 
assuming identical biologic effectiveness. It is possible to reweight tritium based on its 
relative effectiveness to gamma radiation and sum these values as a single exposure metric; 
this is common practice in radiation epidemiology. However, this requires assigning a fixed 
value to the relative effectiveness of tritium to gamma radiation. The order constraint of our 
analysis is more flexible and allows for the variation present in each exposure measure to 
characterize its distribution. By not summing doses based on a fixed weighting factor, the 
investigation also avoids exposure misclassification that would occur if the fixed value is 
incorrect. This is a concern because experimental research supports tritium’s increased 
biologic effectiveness relative to gamma radiation, but does not support a fixed value for any 
one outcome of interest.
When comparing a model without an order constraint prior to a model that integrates the 
constraint β2 ≥ β1, the precision of all model parameters improves. The parameter with the 
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largest increase in precision from the use of truncation is the estimate of the relationship 
between tritium and leukemia excluding chronic lymphocytic leukemia. When we truncate 
estimation of tritium in this model, the estimate shifts from an implausible negative value to 
a positive value. The observation of a negative relationship between tritium and leukemia 
risk is counter to both the evidence of its biologic effectiveness relative to gamma radiation 
and evidence of radiation as a leukemogen.31,32 The confidence limit ratio for β2 in the 
unconstrained model for leukemia excluding chronic lymphocytic leukemia is more than 
twice the value in the constrained model, whereas the confidence limit ratio in the 
unconstrained model for leukemia including chronic lymphocytic leukemia is larger by less 
than half (Table 2). This difference is consistent with the smaller sample size and greater 
potential for influence of a small number of leukemia cases after excluding chronic 
lymphocytic leukemia. Specifically, the exclusion of cases of chronic lymphocytic leukemia 
(26% of all cases) combined with the fact that cumulative tritium dose is much lower than 
the cumulative gamma dose received by the Savannah River Site cohort (56.2 Sv compared 
with 475 Sv) lead to a situation where there is not enough information to reliably estimate a 
dose-response relationship between tritium and leukemia risk with data alone. Exposure 
misclassification may also contribute to the fact that the risk coefficient is negative. Because 
tritium has a short biologic half-life (about 10 days), a very frequent monitoring regimen is 
necessary to accurately assess employees’ tritium doses33; such a program was not in place 
for all workers at Savannah River Site over the entire history of the site’s operation.18 As a 
result, records may not accurately represent individuals’ tritium doses, leading to attenuation 
of its relationship to cancer risk. In fact, misclassification of either exposure will influence 
the effectiveness of the constraint. Since we implement our constraint using a Bayesian 
approach, if knowledge regarding misclassification of either exposure is available, this 
information may be added to the model to further inform the estimation of the exposure that 
is subject to influence from the constraint.
In our empirical example, the fact that both tritium and gamma radiation are measured in the 
same units (Sieverts) allows for a direct application of the order constraint to the data as is. 
However, in the case where the user intends to specify an ordered structure to exposures 
measured in different units, it may be necessary to recalculate the units for exposures so that 
their coefficients are measured on a single scale, such as parts per million for particulate 
matter. Additionally, radiation dose is recorded and examined as a single, continuous term. 
When exposures are measured in categories of exposure, it is still possible to utilize the 
order constraint, although more difficult to specify. Additionally, it would be important for 
the categories of exposure to match one another.
Although we present an example from radiation epidemiology, an order constraint can be 
utilized in many scenarios. We mentioned the case of different congeners and inhaled fibers 
previously34,35; however, any exposures that are the focus of repeated experimental (or 
epidemiologic) research may benefit from the use of an order constraint, if knowledge 
external to a particular study is available. In the case that the investigator has prior 
knowledge that the effect of second exposure is x units larger than the first exposure, the 
constraint may be readily adapted: for instance, instead of specifying β2 ≥ β1, the user may 
specify β2≥ β1 + x. Additionally, order-constrained priors can improve risk estimates for 
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ordinal categories of a single exposure by informing those with sparse data based on 
adjacent categories of exposure with more information, assuming we have evidence of the 
shape of the relationship; for instance, a monotonically increasing incidence of lung cancer 
associated with increased number of pack-years of cigarettes smoked.
When utilizing the order constraint for distinct exposures, researchers should ensure that its 
use is well supported by prior research whose results have been repeated. If the assumptions 
that are integrated into analyses via the order constraint are faulty, as with any other 
incorrect assumption, the results can be biased. In general application, when the parameters 
do not violate the order constraint and both are well informed by the data, the order 
constraint will have diminishing impact on the parameter estimates. However, in the case 
that the data are in violation of the constraint, the parameter estimates will be biased (see 
eAppendix for simulation results that illustrate this point, http://links.lww.com/EDE/A621).
In conclusion, order-constrained priors may be a useful tool when the researcher has prior 
knowledge concerning the direction and magnitude of a parameter estimate of interest 
relative to another parameter in the same regression model. An appealing aspect of this 
approach is that the researcher is not required to synthesize evidence from multiple sources 
to calculate a prior distribution for any parameter in the regression model. Rather, simple 
knowledge of the direction of effect of one parameter relative to another is sufficient. Thus, 
implementation of this method is straightforward, and we hope that this approach will be 
appealing to Bayesians and frequentists alike. The eAppendix (http://links.lww.com/EDE/
A621) provides an example of specification of the order-constrained prior.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Posterior distribution of estimates of risk of leukemia (left column) and leukemia excluding 
chronic lymphocytic leukemia (right column) associated with gamma (solid line) and tritium 
(dashed line), excluding (upper row) and including (lower row) an order constraint.
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